- Home
- LXP vs BHC Comparison
LXP vs BHC Comparison
Compare LXP & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXP
- BHC
- Stock Information
- Founded
- LXP 1993
- BHC N/A
- Country
- LXP United States
- BHC Canada
- Employees
- LXP N/A
- BHC N/A
- Industry
- LXP Real Estate Investment Trusts
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- LXP Real Estate
- BHC Health Care
- Exchange
- LXP Nasdaq
- BHC Nasdaq
- Market Cap
- LXP 3.0B
- BHC 3.0B
- IPO Year
- LXP 1993
- BHC N/A
- Fundamental
- Price
- LXP $9.75
- BHC $8.33
- Analyst Decision
- LXP Buy
- BHC Hold
- Analyst Count
- LXP 3
- BHC 4
- Target Price
- LXP $11.33
- BHC $6.63
- AVG Volume (30 Days)
- LXP 2.3M
- BHC 2.4M
- Earning Date
- LXP 10-29-2024
- BHC 10-31-2024
- Dividend Yield
- LXP 5.33%
- BHC N/A
- EPS Growth
- LXP N/A
- BHC N/A
- EPS
- LXP 0.09
- BHC N/A
- Revenue
- LXP $340,415,000.00
- BHC $9,202,000,000.00
- Revenue This Year
- LXP N/A
- BHC $9.58
- Revenue Next Year
- LXP $5.74
- BHC $3.68
- P/E Ratio
- LXP $109.63
- BHC N/A
- Revenue Growth
- LXP 2.13
- BHC 10.20
- 52 Week Low
- LXP $7.75
- BHC $3.96
- 52 Week High
- LXP $10.57
- BHC $11.46
- Technical
- Relative Strength Index (RSI)
- LXP 35.63
- BHC 76.14
- Support Level
- LXP $10.10
- BHC $8.10
- Resistance Level
- LXP $10.29
- BHC $8.32
- Average True Range (ATR)
- LXP 0.15
- BHC 0.28
- MACD
- LXP -0.06
- BHC 0.02
- Stochastic Oscillator
- LXP 12.99
- BHC 89.78
About LXP LXP Industrial Trust (Maryland REIT)
LXP Industrial Trust is a real estate investment trust principally involved in the ownership of equity and debt investments in single-tenant properties and land throughout the United States. Majority of the revenue is earned through rental revenue.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.